Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
131326-39-1
1170231-23-8
1900735-92-3
203642-77-7
1351398-45-2 | 3-(4-Ethoxybenzenesulfonyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-7-carboxylic acid | AA00HTTO | MFCD20528974
1355247-62-9 | Methyl 3-cyclopropylbenzimidazole-5-carboxylate | AA00HU4R | MFCD21332959
1363210-51-8 | 8-tert-Butyl 2-methyl 1-hydroxy-8-azaspiro[4.5]decane-2,8-dicarboxylate | AA00HUFP | MFCD22209684
1373028-78-4 | tert-Butyl 2-(hydroxymethyl)-1-oxa-8-azaspiro[4.5]decane-8-carboxylate | AA00HURZ | MFCD22209763
1384265-63-7 | Methyl 6-fluoro-4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate | AA00HV7R | MFCD22573693
1394957-34-6 | 1-Fluoro-2-methyl-4-nitro-5-(propan-2-yloxy)benzene | AA00HVJJ | MFCD23113583
141305-55-7 | 4-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride | AA00HVWY | MFCD22046795
1421372-18-0 | 5-Methyl-2,5-diazaspiro[3.4]octane 2HCl | AA00HWA6 | MFCD23703377
1427446-94-3 | 2-Bromo-1-(2-bromo-5-fluorophenyl)ethan-1-one | AA00HWIU | MFCD23711741
1434141-75-9 | 5-(tert-Butoxycarbonylamino-methyl)cyclohex-1-enecarboxylic acid | AA00HWTN | MFCD26959107
